Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01073 |
| Species: | Homo sapiens |
| Position : | chr17:32565534-32566496 |
| Year: | 2014 |
| Title: | CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | skin melanoma |
| PMID: | 24561613 |
| MONDO: | MONDO:0005105 |
| Tissue: | Skin |
| Tissue Ontology ID: | UBERON:0000014 |
| Cell Source: | SK-MEL28 |
| CVCL ID: | CVCL_0526 |
| Cell Type: | melanoma cell |
| Cell Ontology ID: | CL:0002573 |
| Experiment Type: | Functional perturbation assay, Enhancer activity assay |
| High Throughput Method: | ChIP-seq, RNA-seq |
| Low Throughput Method: | CRISPR Knockout, CRISPRi, ChIP-RT-qPCR, RT-RT-qPCR |
| Target gene : | CCL2 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|